.I have only just started looking at IXC so apologies if this has already been discussed
IXC certainly looks undervalued but I am trying to understand its potential value in different scenarios.
IF IXC successfully repurposes its drug (Exenatide ?), and although this seems probable, it may take a "while". So what is to stop a generic from appearing within a few years of IXC's drug being approved and being a market success?
IXC Price at posting:
70.5¢ Sentiment: Hold Disclosure: Not Held
